Pocenbrodib hydrochloride is under clinical development by Pathos AI and currently in Phase I for Metastatic Castration-Resistant Prostate Cancer (mCRPC).

We talked about how marketers and writers and artists reach their audience: are they using ethos (credibility), pathos (emotional appeal), or logos (statistical facts or reasoning) to make a pitch or ...

PR firm Pathos Communications has been recognised by the 2024 UK Fast Growth Index as the fastest-growing professional services company. London, United Kingdom--(Newsfile Corp. - December 11 ...